Changing phenotype of celiac disease after long-term gluten exposure.

Celiac disease is an autoimmune disorder wherein the ingestion of gluten causes villous atrophy of the small intestinal mucosa with crypt hyperplasia in genetically susceptible individuals. The classic symptoms are malabsorption, steatorrhea, weight loss, growth retardation, and failure to thrive (1,2). Dermatitis herpetiformis is a well-known extraintestinal manifestation of celiac disease, characterized by granular immunoglobulin A (IgA) deposits in uninvolved skin (3). Approximately 17% of celiac patients have dermatitis herpetiformis (4). Celiac disease can appear at any age after gluten has been introduced into the diet, whereas dermatitis herpetiformis usually manifests in adulthood, the median age of diagnosis being about 40 years (4). It remains obscure why some patients experience celiac disease, overt enteropathy, and no skin involvement, whereas some experience dermatitis herpetiformis with often only mild enteropathy. The following 3 case reports indicate that periods of gluten intake and gluten withdrawal may have an impact on disease expression, and the phenotype may vary in the same person over time.

[1]  N. Croft Gluten-free diets in celiac disease: does life mean life? , 2008, Gastroenterology.

[2]  K. Kaukinen,et al.  Latent coeliac disease or coeliac disease beyond villous atrophy? , 2007, Gut.

[3]  L. Virta,et al.  The diagnostic criteria of coeliac disease , 2007, Acta paediatrica.

[4]  N. Brousse,et al.  Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet , 2007, Gut.

[5]  L. Virta,et al.  Diagnosis of Celiac Disease in Clinical Practice: Physician's Alertness to the Condition Essential , 2007, Journal of clinical gastroenterology.

[6]  C. Mautalen,et al.  Bone mineral density in children with celiac disease. Effect of a Gluten-free diet , 2006, European Journal of Clinical Nutrition.

[7]  K. Kaukinen,et al.  Is coeliac disease screening in risk groups justified? A fourteen‐year follow‐up with special focus on compliance and quality of life , 2005, Alimentary pharmacology & therapeutics.

[8]  J. Ilonen,et al.  Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility , 2005, Scandinavian journal of gastroenterology.

[9]  K. Lundin Commentary: Transient coeliac disease back on stage again? , 2005, Scandinavian journal of gastroenterology.

[10]  I. Korponay-Szabó,et al.  In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies , 2004, Gut.

[11]  J. Partanen,et al.  Concordance of dermatitis herpetiformis and celiac disease in monozygous twins. , 2000, The Journal of investigative dermatology.

[12]  M. Mäki,et al.  Osteopenia in patients with clinically silent coeliac disease warrants screening , 1999, The Lancet.

[13]  L. Stenhammar,et al.  Very late mucosal relapse in a girl with coeliac disease , 1993, Acta paediatrica.

[14]  T. Reunala,et al.  Increase of lymphocytes bearing the gamma/delta T cell receptor in the jejunum of patients with dermatitis herpetiformis. , 1992, Gut.

[15]  M. Mäki,et al.  Coeliac-type dental enamel defects in patients with dermatitis herpetiformis. , 1992, Acta dermato-venereologica.

[16]  T. Reunala,et al.  Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet. , 1984, Archives of disease in childhood.

[17]  M. Ashina,et al.  Clinical Guideline , 2020, Encyclopedia of Behavioral Medicine.

[18]  T. Reunala,et al.  Recognition and Management of the Cutaneous Manifestations of Celiac Disease , 2003, American journal of clinical dermatology.

[19]  Richard J Farrell,et al.  Celiac sprue. , 2002, The New England journal of medicine.